APA
BSTC

American Portfolios Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

American Portfolios Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,076
Closed -$56.8K – 3141
2020
Q3 		$56.8K Hold
1,076
– – ﹤0.01% 1277
2020
Q2 		$65.9K Hold
1,076
– – ﹤0.01% 1189
2020
Q1 		$60.9K Hold
1,076
– – 0.01% 1084
2019
Q4 		$61.3K Hold
1,076
– – ﹤0.01% 1269
2019
Q3 		$57.6K Hold
1,076
– – ﹤0.01% 1222
2019
Q2 		$64.2K Sell
1,076
-24
-2% -$1.51K 0.01% 1165
2019
Q1 		$68.6K Hold
1,100
– – 0.01% 1057
2018
Q4 		$66.7K Buy
+1,100
New +$65.7K 0.01% 896

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

American Portfolios Advisors's BSTC Position: Q4 2020 in Review

American Portfolios Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 1,076 shares — an estimated $56.8K sold.

American Portfolios Advisors first reported a position in BSTC in Q4 2018 and held it in 8 quarters. The position peaked at $68.6K in Q1 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • American Portfolios Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • American Portfolios Advisors sold 1,076 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $56.8K.
  • American Portfolios Advisors first reported a position in BioSpecifics Technologies Corp. in Q4 2018 and held it in 8 quarters.
  • American Portfolios Advisors's BioSpecifics Technologies Corp. position peaked at $68.6K in Q1 2019.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on American Portfolios Advisors's 13F filing for Q4 2020, filed 22 Mar 2023.